| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |